Real-time changes in 1H and 31P NMR spectra of malignant human mammary epithelial cells during treatment with the anti-inflammatory agent indomethacin.
about
Future technology insight: mass spectrometry imaging as a tool in drug research and development.Choline kinase and its functionCEST-MRI detects metabolite levels altered by breast cancer cell aggressiveness and chemotherapy responseMetabolomic Characterization of Ovarian Epithelial Carcinomas by HRMAS-NMR SpectroscopyMechanisms of indomethacin-induced alterations in the choline phospholipid metabolism of breast cancer cells.Anti-inflammatory agent indomethacin reduces invasion and alters metabolism in a human breast cancer cell linePattern recognition and biomarker validation using quantitative 1H-NMR-based metabolomics.Therapeutic targets and biomarkers identified in cancer choline phospholipid metabolism.Application of metabonomics in drug development.Quantification of choline- and ethanolamine-containing metabolites in human prostate tissues using 1H HR-MAS total correlation spectroscopy.Time-dependent effects of imatinib in human leukaemia cells: a kinetic NMR-profiling study.Noninvasive detection of lentiviral-mediated choline kinase targeting in a human breast cancer xenograftMolecular Imaging of Cancer: Applications of Magnetic Resonance Methods.Toward digital staining using imaging mass spectrometry and random forests.MR evaluation of response to targeted treatment in cancer cells.Increased activity of CHK enhances the radioresistance of MCF-7 breast cancer stem cells.The Tumor Microenvironment Modulates Choline and Lipid Metabolism.Phenylbutyrate induces apoptosis and lipid accumulations via a peroxisome proliferator-activated receptor gamma-dependent pathway.Applications of high-resolution magic angle spinning MRS in biomedical studies II-Human diseases.
P2860
Q28087460-1C074A8E-0A4E-4847-9927-96D8BE4A036FQ28288614-7EB16797-1BB6-4CEF-BED0-57714B6A73E8Q31082468-BAFB1766-BF70-4688-9307-DB73007D98E3Q34960082-639E3412-A16E-48CE-B3FE-48BB7BC8E9CDQ35060329-C7CBE187-0A04-46DE-A76C-A9F302C996EEQ35728009-FA8C851A-52C3-46B1-A428-42BE7FC9FDC7Q36607286-BF6E5074-B242-4C3A-A9F0-5863FD9C2954Q36630017-C23C4A61-AABF-44D7-AE4A-F546D287DDE5Q37074082-DBD29913-E483-4020-A818-9A30D01FBE34Q37100440-DE7E0F73-FA84-4865-8AB2-71DD1A41744EQ37141914-17F26DDA-102F-480B-BA9F-0D2E5C68EF45Q37204053-EBB9AD85-9388-44CA-A9E3-9647AC6A42E1Q37359297-8384D05A-5CD1-47D8-A644-CA9E1DD324A5Q37390707-C8560B15-7894-4EF9-B58F-B9B5206EE4E0Q37851076-FD422AB1-B237-4388-93CD-EE42EB8D57F9Q38801460-014C8C5A-E641-489C-84EA-F34DC04AB885Q39032724-E489EE9D-7A9A-464E-BDA7-038E2D35569DQ39728530-38DC18EE-1B74-4C38-881F-665B9CD8E6ABQ48338205-A9DDBB25-5D60-4DCF-9B5E-C137935FB384
P2860
Real-time changes in 1H and 31P NMR spectra of malignant human mammary epithelial cells during treatment with the anti-inflammatory agent indomethacin.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Real-time changes in 1H and 31 ...... flammatory agent indomethacin.
@ast
Real-time changes in 1H and 31 ...... flammatory agent indomethacin.
@en
type
label
Real-time changes in 1H and 31 ...... flammatory agent indomethacin.
@ast
Real-time changes in 1H and 31 ...... flammatory agent indomethacin.
@en
prefLabel
Real-time changes in 1H and 31 ...... flammatory agent indomethacin.
@ast
Real-time changes in 1H and 31 ...... flammatory agent indomethacin.
@en
P2093
P2860
P356
P1476
Real-time changes in 1H and 31 ...... nflammatory agent indomethacin
@en
P2093
Dmitri Artemov
Kristine Glunde
Kshama Natarajan
Zaver M Bhujwalla
P2860
P304
P356
10.1002/MRM.10295
P577
2002-11-01T00:00:00Z